Ketamine Therapy in Kelowna

ATMA CENA does not operate a clinic in British Columbia. This article is for Kelowna and Okanagan patients who want an honest map of what's locally available — and how ATMA CENA's coordinated care model can still support care while a Kelowna-area therapist remains the primary therapeutic relationship. Kelowna is BC's interior ketamine therapy hub: EntheoMed at 1131 Lawson Avenue runs the established IM ketamine + psychotherapy program (the "Odyssey Method"), Field Trip Health offers an at-home model, and Kaizen Wellness Centre at 1631 Dickson Avenue offers KAP through a Revelation Psychedelic Therapy partnership. Interior Health does not operate a publicly funded outpatient psychiatric ketamine program.

Key takeaways

• ATMA CENA does NOT operate a Kelowna or BC member clinic. Kelowna patients can still work with ATMA CENA via the coordinated care model — the existing therapist remains the primary therapeutic relationship while ATMA CENA's network provides medical oversight and infrastructure.
• Active Kelowna providers: EntheoMed (1131 Lawson Avenue), Field Trip Health (at-home), Kaizen Wellness Centre (1631 Dickson Avenue).
• CPSBC's August 2025 ketamine guidance applies to Kelowna; off-label parenteral ketamine requires accredited non-hospital medical/surgical facility (NHMSFAP) credentialing.
• BC PharmaCare made a non-benefit decision on Spravato — patients pay privately or seek out-of-province coverage.
• Kelowna serves as the Okanagan's ketamine therapy hub for patients in Vernon, Penticton, and West Kelowna.

ATMA CENA in Kelowna: an honest picture

ATMA CENA's corporate clinics are in Edmonton and Calgary, with member clinics across Alberta, Ontario, Manitoba, Saskatchewan, and Quebec. ATMA CENA does not operate in BC. The honest framing for a Kelowna patient researching ketamine therapy:

1. The ATMA CENA information call can help you map options without prescribing them: confirm whether a local provider's model fits your indication, evaluate insurance pathways, and discuss whether the coordinated care model — your existing Kelowna therapist working with ATMA CENA's medical infrastructure — is the right approach.
2. The coordinated care model lets a Kelowna-area therapist (RCC, RP, RSW, psychologist) remain your primary therapeutic relationship while ATMA CENA's network provides physician oversight, screening, and dosing infrastructure.
3. Local Kelowna options are reviewed below.

What is ketamine-assisted therapy?

Ketamine therapy uses sub-anaesthetic doses of ketamine — a Health Canada-approved anaesthetic — to treat conditions including treatment-resistant depression, PTSD, anxiety, OCD, and chronic pain. Health Canada has approved ketamine as an anaesthetic; psychiatric use is off-label, a legal and common practice in Canadian medicine. Spravato (intranasal esketamine) is Health Canada-approved for treatment-resistant MDD as of May 2020.

When ketamine is paired with structured psychotherapy before, during, and after dosing, the treatment is called ketamine-assisted psychotherapy (KAP) or ketamine-assisted therapy (KAT). For the full mechanism breakdown, see What Is Ketamine Therapy?.

How ketamine works

Ketamine acts on the brain's glutamate system through NMDA (N-methyl-D-aspartate) receptor antagonism, triggering a downstream surge of glutamate, AMPA receptor activation, and BDNF (brain-derived neurotrophic factor) release that stimulates synaptogenesis — the formation of new neural connections within 24 to 72 hours of a dose (Lullau et al., 2023). Conventional antidepressants take 4 to 6 weeks to act; ketamine can produce antidepressant effects within 2 to 72 hours of a single IV dose. The Canadian Network for Mood and Anxiety Treatments (CANMAT) places IV racemic ketamine as a third-line treatment for adults with treatment-resistant depression (TRD) (Swainson et al., 2021).

Kelowna's ketamine landscape

Public sector

Kelowna General Hospital and Interior Health do not operate a publicly funded outpatient psychiatric ketamine program at the time of writing. Mental Health and Substance Use Services Interior provides general psychiatric care; ketamine is not a routine offering.

BC regulatory framework

Federal — Health Canada. Ketamine is a Schedule I controlled substance, prescribed off-label for psychiatric use. Spravato is Health Canada-approved for TRD as of May 2020.

Provincial — College of Physicians and Surgeons of BC (CPSBC). CPSBC published an August 2025 update to its interim guidance on ketamine administration via intramuscular, oral, sublingual, and intranasal routes for mental health and chronic pain in community settings. Key requirements: practitioners must have the knowledge, skill, and judgment to administer sub-anaesthetic ketamine safely; immediate access to adverse-event management equipment; written informed consent for off-label use. Off-label parenteral ketamine (IV/IM/SQ) in non-hospital settings requires accreditation under the Non-Hospital Medical and Surgical Facilities Accreditation Program (NHMSFAP). Intranasal esketamine (Spravato) has separate CPSBC guidance permitting administration in non-accredited clinics by psychiatrists enrolled in the Janssen Journey Program.

BCCNM and BCACC. NPs prescribe Schedule I/IA/II drugs subject to BCCNM standards. RCCs registered with BCACC operate within multidisciplinary KAP teams in BC, particularly in preparation and integration roles.

BC public coverage and insurance

BC PharmaCare — Spravato (esketamine). BC PharmaCare made a non-benefit decision: Spravato is not covered. The Common Drug Review recommended against listing for MDD, citing uncertain meaningful benefit. Spravato access in BC is private-pay or via patient assistance programs.

MSP (BC Medical Services Plan). Covers physician consultations but not ketamine drug or administration for psychiatric indications.

WorkSafeBC. Reviews ketamine claims case-by-case.

Veterans Affairs Canada. Covers ketamine drug forms (IV, oral, intranasal, compounded cream) for service-related TRD and chronic pain on a case-by-case basis. VAC does not specifically cover ketamine-assisted psychotherapy at the time of last review.

Private insurance. Coverage varies. Spravato is the form most likely to be covered with prior authorization for documented TRD. Generic IV/IM ketamine for psychiatric use is generally not covered. Alberta Blue Cross's psychedelic-assisted therapy coverage does not extend to BC residents.

For full insurance navigation, see Insurance Coverage for Ketamine Therapy.

What does ketamine therapy cost in Kelowna?

For the full Canadian pricing breakdown, see Ketamine Therapy Cost in Canada.

Who is a candidate?

Most Canadian ketamine programs use the following inclusion criteria:

• Adults 18 or older
• Diagnosis of TRD (failure of 2+ adequate antidepressant trials), bipolar depression with mood-stabilizer coverage, PTSD, anxiety disorders, OCD, or chronic pain
• Medically stable; able to provide informed consent

Absolute contraindications: active psychosis, uncontrolled severe hypertension, severe cardiovascular disease, current pregnancy, anaphylactic reaction to ketamine, active manic episode. For full eligibility detail, see How to Qualify for Ketamine Therapy in Canada.

Local Kelowna practical notes

• Population: Kelowna CMA ~247k–254k; city population ~165k–173k
• Major hospitals: Kelowna General Hospital, BC Cancer Agency Sindi Ahluwalia Hawkins Centre
• Universities: UBC Okanagan
• Catchment: Central Okanagan + regional draw from West Kelowna, Lake Country, Vernon (~50 km), Penticton (~60 km), Kamloops (~165 km)
• Travel: Kelowna International Airport (YLW) — patients fly in from across BC interior
• Transit: BC Transit Kelowna
• Post-session: 24-hour no-driving rule; arrange a designated driver, rideshare, or transit

Frequently asked questions

Does ATMA CENA have a clinic in Kelowna? No. ATMA CENA does not operate a clinic in BC. Kelowna patients can still work with ATMA CENA via the coordinated care model — your Kelowna therapist remains the primary therapeutic relationship while ATMA CENA's network provides medical oversight and infrastructure.

Who runs EntheoMed Kelowna? EntheoMed's Medical Director is Dr. Anita Sanan (anesthesiology), with co-leadership including Dr. Francois Louw (GP, anesthesiology, ER, pain medicine; Chief Medical Officer of EntheoTech) and Dr. Michael Ocana (psychiatry) historically associated. The Odyssey Method is a 4-week IM ketamine + psychotherapy program with prep and integration.

Does BC PharmaCare cover Spravato? No. BC PharmaCare made a non-benefit decision. Patients pay privately or seek out-of-province coverage.

Is there a public hospital ketamine program in the BC interior? Kelowna General Hospital and Interior Health do not operate a publicly funded outpatient psychiatric ketamine program at the time of writing.

How much does ketamine therapy cost in Kelowna? Pricing varies by clinic. Confirm program totals with EntheoMed, Field Trip, and Kaizen directly. ATMA CENA's network pricing for KAT (via coordinated care or referral to a network clinic) ranges CAD $1,530–$6,930 per program.

Do I need a doctor's referral? Most BC private clinics including EntheoMed, Field Trip, and Kaizen accept self-referrals. Confirm at intake.

Can I drive after a ketamine session? No. Patients cannot drive for at least 24 hours after a session. BC Transit Kelowna and rideshare are practical alternatives.

Can my existing Kelowna therapist work with ATMA CENA network? Yes — through the coordinated care model. Your Kelowna therapist (RCC, RP, RSW, psychologist) can remain the primary therapeutic relationship while ATMA CENA's network provides medical oversight and infrastructure. ATMA CENA's clinical team will discuss what this looks like in practice.

Sources

1. ATMA CENA — Find care near you: https://psychedelic.healthcare/find-care/
2. CPSBC — Ketamine Administration via IM/Oral/Sublingual/Intranasal Routes (August 2025): https://www.cpsbc.ca/files/pdf/IG-Ketamine-Administration-via-Intramuscular-Oral-Sublingual-Intranasal-Routes.pdf
3. CPSBC — Clarification on Intranasal Esketamine: https://www.cpsbc.ca/news/clarification-college-requirements-intranasal-esketamine
4. BC PharmaCare — Esketamine (Spravato) decision: https://www2.gov.bc.ca/assets/gov/health/health-drug-coverage/pharmacare/decisions/esketamine_hydrochloride_spravato_dds.pdf
5. EntheoMed Kelowna: https://entheomed.ca/
6. Field Trip Health Kelowna: https://fieldtriphealth.ca/locations/kelowna/
7. Kaizen Wellness Centre: https://kaizenwellnesscentre.com/
8. Veterans Affairs Canada — Mental Health Benefits: https://www.veterans.gc.ca/en/financial-programs-and-services/medical-costs/coverage-services-prescriptions-and-devices/mental-health-benefits
9. Health Canada DPD — Spravato: https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98903
10. Lullau APM, et al. (2023). Antidepressant mechanisms of ketamine. Front Neurosci. https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2023.1223145/full
11. Swainson J, et al. (2021). CANMAT racemic ketamine recommendations. Can J Psychiatry. https://pubmed.ncbi.nlm.nih.gov/33174760/

Related articles in this cluster

• Ketamine Therapy in Canada
• What Is Ketamine Therapy?
• Ketamine Therapy Cost in Canada
• How to Qualify for Ketamine Therapy in Canada
• Ketamine Therapy for Depression
• Ketamine Therapy in Vancouver
• Ketamine Therapy in Victoria BC
• Ketamine Therapy in Calgary
• Insurance Coverage for Ketamine Therapy
• Find care near you

Last updated: 2026-05-05